Moleculin Biotech (MBRX)
(Delayed Data from NSDQ)
$0.41 USD
+0.02 (4.60%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $0.39 -0.02 (-5.34%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth B Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Moleculin Biotech, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MBRX 0.41 +0.02(4.60%)
Will MBRX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MBRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MBRX
Moleculin Biotech (MBRX) Upgraded to Buy: Here's What You Should Know
Here's Why Moleculin Biotech (MBRX) Is a Great 'Buy the Bottom' Stock Now
MBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Moleculin Biotech (MBRX) Rating Upgrade to Buy
Other News for MBRX
MBRX forms MACD Bullish Signal Line Cross on September 18
12 Health Care Stocks Moving In Thursday's After-Market Session
Is MBRX poised for gains? Hammer Candlestick shows up after advancing 0.75%
Is MBRX set to rally? Hammer Candlestick shows up after gaining 2.17%
MBRX forms Narrow Range Bar on September 12